Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genetic Lingo01:11

Genetic Lingo

113.7K
Overview
113.7K
Pedigree Analysis01:35

Pedigree Analysis

88.8K
Overview
88.8K
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

727
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
727
Glucose Transporters01:27

Glucose Transporters

27.2K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.2K
Probability Laws01:49

Probability Laws

43.9K
Overview
43.9K
Pleiotropy01:33

Pleiotropy

43.2K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
43.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Objective clinical scoring system and diagnostic variability in idiopathic pulmonary fibrosis.

BMC pulmonary medicine·2026
Same author

Imaging the Spectrum of Mediastinitis.

Seminars in roentgenology·2025
Same author

Giant Left Atrial Myxoma Presenting with Severe Pulmonary Hypertension.

US cardiology·2024
Same author

Imaging of Lung Transplantation.

Clinics in chest medicine·2024
Same author

Practice Patterns for Screening and Treating Interstitial Lung Disease-related Pulmonary Hypertension at Specialty Care Centers in the United States.

Annals of the American Thoracic Society·2024
Same author

CT Approach to Lung Injury.

Radiographics : a review publication of the Radiological Society of North America, Inc·2023

Related Experiment Video

Updated: Jan 14, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

14.2K

Birt-Hogg-Dubé Syndrome.

Tej M Patel1, Michael A Beal2, Gabriel Schroeder1

  • 1Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, Campus Box 8052, 4523 Clayton Avenue, St Louis, MO 63110, USA.

Clinics in Chest Medicine
|October 19, 2025
PubMed
Summary

Birt-Hogg-Dubé syndrome, a rare genetic disorder, presents with lung cysts, kidney tumors, and skin lesions. Early diagnosis and management are crucial for patient outcomes.

Keywords:
BHDChromophobe renal tumorsFibrofolliculomasFolliculinOncocytic renal tumorsPneumothoraxPulmonary cystsTrichodiscomas

More Related Videos

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome
06:48

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome

Published on: March 23, 2022

2.7K
In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

21.2K

Related Experiment Videos

Last Updated: Jan 14, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

14.2K
Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome
06:48

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome

Published on: March 23, 2022

2.7K
In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

21.2K

Area of Science:

  • Genetics
  • Oncology
  • Pulmonology

Background:

  • Birt-Hogg-Dubé (BHD) syndrome is a rare autosomal dominant genetic disorder.
  • It results from mutations in the folliculin (FLCN) gene, affecting cellular growth and metabolism.
  • BHD syndrome is associated with a characteristic triad of clinical manifestations.

Purpose of the Study:

  • To summarize the key features of BHD syndrome.
  • To outline diagnostic approaches.
  • To describe current management strategies.

Main Methods:

  • Clinical examination findings.
  • Radiographic imaging interpretation.
  • Histopathological analysis.
  • Genetic testing for FLCN mutations.

Main Results:

  • Clinical triad includes pulmonary cysts (risk of pneumothorax), renal tumors (mixed subtypes), and cutaneous fibrofolliculomas.
  • Diagnosis requires a combination of clinical, imaging, histopathological, and genetic data.
  • Management involves pleurodesis for pneumothorax, surveillance for renal tumors, and family screening.

Conclusions:

  • BHD syndrome diagnosis is complex, necessitating a multidisciplinary approach.
  • Prompt intervention for pneumothorax and vigilant renal tumor surveillance are essential.
  • Genetic testing and family screening are vital components of comprehensive BHD syndrome management.